scholarly journals Dengue Virus Infection of Primary Endothelial Cells Induces Innate Immune Responses, Changes in Endothelial Cells Function and Is Restricted by Interferon-Stimulated Responses

2015 ◽  
Vol 35 (8) ◽  
pp. 654-665 ◽  
Author(s):  
Julie K. Calvert ◽  
Karla J. Helbig ◽  
David Dimasi ◽  
Michaelia Cockshell ◽  
Michael R. Beard ◽  
...  
2012 ◽  
Vol 132 (8) ◽  
pp. 2103-2105 ◽  
Author(s):  
Pornapat Surasombatpattana ◽  
Sirilaksana Patramool ◽  
Natthanej Luplertlop ◽  
Hans Yssel ◽  
Dorothée Missé

2010 ◽  
Vol 9 (10) ◽  
pp. 4960-4971 ◽  
Author(s):  
Rattiyaporn Kanlaya ◽  
Sa-nga Pattanakitsakul ◽  
Supachok Sinchaikul ◽  
Shui-Tein Chen ◽  
Visith Thongboonkerd

2016 ◽  
Vol 6 (2) ◽  
pp. 39
Author(s):  
Nasronudin Nasronudin

Currently by an estimated 50-100 million dengue fever cases per year in worldwide, 500.000 were in the form of a disease is heavyDengue Hemorraghic Fever (DHF) and Dengue Shock Syndrome (DSS). Survey serology in Indonesia show that DEN-1 and DEN-2 arethe dominant serotipe virus until the end of the 1980s but the recent shift has occurred epizoötic where viruses DEN-3 dominant. (DosSantos, 2004; Malavige, 2004; Stephenson, 2005). Dengue virus infection induces transient immune aberrant activation of CD4/CD8ratio inversion and cytokine overproduction, and infection of endothelial cells and hepatocytes causes apoptosis and dysfunction ofthese cells. The aberrant immune responses not only impaire the immune response to clear the virus, but also result in overproductionof cytokines that affect monocytes, endothelial cells, and hepatocytes. Dengue-virus-induced vasculopathy and coagulopathy must beinvolved in the pathogenesis of hemorrhage, and the unbalace between coagulation and fibrinolysis activation, and prolonged durationof shock increase the likelihood of severe hemorrhage in DHF/DSS. Capillary leakage is triggered by the dengue virus itself or byantibodies to its antigen. To date, there are no effective strategies to prevent the progression of DHF/DSS. The control of dengue willbe possible only after an efficient vaccine has been developed


2014 ◽  
Vol 11 (6) ◽  
pp. 538-544 ◽  
Author(s):  
Sazaly AbuBakar ◽  
Meng-Hooi Shu ◽  
Jefree Johari ◽  
Pooi-Fong Wong

PLoS ONE ◽  
2012 ◽  
Vol 7 (7) ◽  
pp. e41932 ◽  
Author(s):  
Siew Pei Ong ◽  
Ling Min Lee ◽  
Yew Fai Ivan Leong ◽  
Mah Lee Ng ◽  
Justin Jang Hann Chu

Sign in / Sign up

Export Citation Format

Share Document